Inhibition of human B cell responses in vitro by RS-61443, cyclosporine A and DAB486 IL-2.
Grailer
A
A
Department of Surgery, University of Wisconsin Clinical Sciences Center, Madison.
Nichols
J
J
Hullett
D
D
Sollinger
H W
HW
Burlingham
W J
WJ
D000917:Antibody Formation / Q000187:drug effects; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D003524:Cyclosporins / Q000494:pharmacology*; D004168:Diphtheria Toxoid / Q000494:pharmacology*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007376:Interleukin-2 / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D011993:Recombinant Fusion Proteins / Q000494:pharmacology; D013154:Spleen / Q000276:immunology
D003524:Cyclosporins; D004168:Diphtheria Toxoid; D007074:Immunoglobulin G; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; D009173:Mycophenolic Acid